BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 32099350)

  • 21. Daily physical activity and related risk factors in COPD.
    Albarrati AM; Gale NS; Munnery MM; Cockcroft JR; Shale DJ
    BMC Pulm Med; 2020 Mar; 20(1):60. PubMed ID: 32138714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation.
    Pirard L; Marchand E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3963-3970. PubMed ID: 30573956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD.
    Ong KC; Earnest A; Lu SJ
    Chest; 2005 Dec; 128(6):3810-6. PubMed ID: 16354849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between oral health and COPD exacerbations.
    Baldomero AK; Siddiqui M; Lo CY; Petersen A; Pragman AA; Connett JE; Kunisaki KM; Wendt CH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():881-892. PubMed ID: 31114185
    [No Abstract]   [Full Text] [Related]  

  • 30. Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations: A Multicenter 4½ Year Prospective Cohort Study.
    Strassmann A; Frei A; Haile SR; Ter Riet G; Puhan MA
    Chest; 2017 Dec; 152(6):1179-1187. PubMed ID: 28923760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic assessment in COPD without lung function: the B-AE-D indices.
    Boeck L; Soriano JB; Brusse-Keizer M; Blasi F; Kostikas K; Boersma W; Milenkovic B; Louis R; Lacoma A; Djamin R; Aerts J; Torres A; Rohde G; Welte T; Martinez-Camblor P; Rakic J; Scherr A; Koller M; van der Palen J; Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Tamm M; Stolz D
    Eur Respir J; 2016 Jun; 47(6):1635-44. PubMed ID: 27103389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-component assessment of chronic obstructive pulmonary disease: an evaluation of the ADO and DOSE indices and the global obstructive lung disease categories in international primary care data sets.
    Jones RC; Price D; Chavannes NH; Lee AJ; Hyland ME; Ställberg B; Lisspers K; Sundh J; van der Molen T; Tsiligianni I;
    NPJ Prim Care Respir Med; 2016 Apr; 26():16010. PubMed ID: 27053297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting COPD 1-year mortality using prognostic predictors routinely measured in primary care.
    Bloom CI; Ricciardi F; Smeeth L; Stone P; Quint JK
    BMC Med; 2019 Apr; 17(1):73. PubMed ID: 30947728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients.
    Chen X; Wang Q; Hu Y; Zhang L; Xiong W; Xu Y; Yu J; Wang Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():379-388. PubMed ID: 32110006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Collateral damage: depressive symptoms in the partners of COPD patients.
    Papaioannou AI; Tsikrika S; Bartziokas K; Karakontaki F; Kastanakis E; Diamantea F; Haniotou A; Papiris S; Polychronopoulos V; Loukides S; Kostikas K
    Lung; 2014 Aug; 192(4):519-24. PubMed ID: 24816968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of relevant variables and construction of a multidimensional index for predicting mortality in COPD patients.
    Xu L; Ye T; Li J; Hu Y; Xu W; Wang K; Ou C; Chen X
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1703-1711. PubMed ID: 31534324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
    Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of COPD Exacerbation Frequency on Costs for a Managed Care Population.
    Dalal AA; Patel J; D'Souza A; Farrelly E; Nagar S; Shah M
    J Manag Care Spec Pharm; 2015 Jul; 21(7):575-83. PubMed ID: 26108382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.